Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Aarhus laser botox filler ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   7.5% 7.5% 7.5% 7.5% 7.5% 7.5% 7.5% 7.5%   Bankruptcy risk   24.2% 24.9% 34.0% 13.1% 19.2% 9.6% 12.7% 12.7%   Credit score (0-100)   4 4 1 16 6 24 18 18   Credit rating   B B C BB B BB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -111 241 -43.4 2,211 5,273 7,617 0.0 0.0   EBITDA   -297 -138 -404 484 331 1,792 0.0 0.0   EBIT   -321 -187 -453 408 -327 1,077 0.0 0.0   Pre-tax profit (PTP)   -398.1 -242.0 -495.8 381.1 -351.9 1,040.4 0.0 0.0   Net earnings   -311.3 -328.9 -495.8 540.3 -193.6 807.6 0.0 0.0   Pre-tax profit without non-rec. items   -398 -242 -496 381 -352 1,040 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   41.2 32.1 23.0 501 3,077 3,426 0.0 0.0   Shareholders equity total   -261 -590 -1,086 -546 -739 68.4 18.4 18.4   Interest-bearing liabilities   509 488 0.0 0.0 0.0 0.0 108 108   Balance sheet total (assets)   708 558 565 2,580 4,709 6,473 127 127   Net Debt   508 482 -23.4 -1,374 -218 -1,755 108 108     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -111 241 -43.4 2,211 5,273 7,617 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 0.0% 138.5% 44.4% -100.0% 0.0%   Employees   1 1 1 4 12 14 0 0   Employee growth %   0.0% 0.0% 0.0% 300.0% 200.0% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   708 558 565 2,580 4,709 6,473 127 127   Balance sheet change%   0.0% -21.2% 1.3% 356.6% 82.5% 37.5% -98.0% 0.0%   Added value   -297.1 -137.8 -404.3 484.2 -250.6 1,792.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   197 -98 -98 362 2,045 -426 -3,426 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   290.8% -77.4% 1,045.9% 18.5% -6.2% 14.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -33.2% -17.7% -32.4% 17.1% -7.6% 18.1% 0.0% 0.0%   ROI %   -63.1% -37.5% -185.7% 0.0% 0.0% 3,150.0% 0.0% 0.0%   ROE %   -44.0% -52.0% -88.3% 34.4% -5.3% 33.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   -27.0% -51.4% -65.8% -38.6% -13.6% 1.1% 14.5% 14.5%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -170.8% -350.1% 5.8% -283.7% -66.1% -97.9% 0.0% 0.0%   Gearing %   -194.9% -82.7% 0.0% 0.0% 0.0% 0.0% 588.6% 588.6%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   30.1% 11.1% 17.4% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.4 0.2 0.2 1.2 0.1 0.3 0.0 0.0   Current Ratio   0.5 0.3 0.3 0.6 0.2 0.4 0.0 0.0   Cash and cash equivalent   1.6 5.9 23.4 1,373.5 218.4 1,755.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -482.4 -762.2 -1,208.9 -1,217.7 -4,240.8 -3,726.7 -54.1 -54.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -297 -138 -404 121 -21 128 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -297 -138 -404 121 28 128 0 0   EBIT / employee   -321 -187 -453 102 -27 77 0 0   Net earnings / employee   -311 -329 -496 135 -16 58 0 0